Startseite The R2TP chaperone complex: its involvement in snoRNP assembly and tumorigenesis
Artikel Open Access

The R2TP chaperone complex: its involvement in snoRNP assembly and tumorigenesis

  • Yoshito Kakihara EMAIL logo und Makio Saeki
Veröffentlicht/Copyright: 28. Oktober 2014
Artikel downloaden (PDF)
Biomolecular Concepts
Aus der Zeitschrift Biomolecular Concepts Band 5 Heft 6

Abstract

R2TP was originally identified in yeast Saccharomyces cerevisiae as Hsp90 interacting complex, and is composed of four different proteins: Rvb1, Rvb2, Tah1, and Pih1. This complex is well-conserved in eukaryotes, and is involved in many cellular processes such as snoRNP biogenesis, RNA polymerase assembly, PIKK signaling, and apoptosis. An increasing number of research related to R2TP suggests a linkage of its function with tumorigenesis. In this review, we provide an overview of several recent studies on R2TP that are related to cell proliferation and carcinogenesis, and propose a possible role of R2TP in tumorigenesis through regulating snoRNA/snoRNP biogenesis.

Keywords: box C/D snoRNP; box H/ACA snoRNP; R2TP; snoRNP biogenesis; tumorigenesis

Introduction

R2TP is composed of four different proteins: Rvb1, Rvb2, Pih1, and Tah1. It was initially identified by high-throughput screening of Hsp90 interacting proteins (1). R2TP is conserved from yeast to human, and each component has diverse names because of different naming conventions, as shown in Table 1 (2–5). Rvb1 and Rvb2 belong to the AAA+ (ATPases associated with various cellular activities) superfamily of proteins (5). Pih1 (Protein interacting with Hsp90), which belongs to Pih1 family of proteins, directly interacts with Rvb1-Rvb2 complex (Rvbs) and Tah1 (TPR [tetratricopeptide repeat-containing protein] associated with Hsp90) (1, 3, 6). In yeast, Pih1 is an unstable protein and prone to aggregate in vitro, however, the Pih1 aggregates are dissociated by Hsp90 in an ATP-dependent manner, and its disaggregation activity of Hsp90 is enhanced by Tah1 (6). Tah1 is suggested to function as a co-chaperone of Hsp90 in disaggregating Pih1 (6). As shown in Figure 1, it has been determined that Rvbs are involved in many different cellular processes such as transcriptional regulation, DNA repair, telomerase assembly, and mitotic spindle assembly (7–12), in contrast, when in complex with Tah1 and Pih1, R2TP’s cellular function is limited to apoptosis, PIKK signaling, snoRNP biogenesis, and RNA polymerase II assembly (Figure 1) (2–4, 12, 13). Also, R2TP (or at least Rvbs) is found in ASTRA (ASsembly of Tel, Rvb and Atm-like kinase) complex which is suggested to be involved in telomere maintenance and TORC1 signaling in yeast (14, 15). It has been demonstrated that Pih1 functions as an adaptor protein. In yeast, Pih1 targets R2TP to Nop58 (a core factor in box C/D snoRNP) (16). In mammals, PIH1D1 targets R2TP to dyskerin (yeast Cbf5 homologue, a core factor in box H/ACA snoRNP) (17), Rpb1 (a core subunit in RNA polymerase II) (18), and Tel2 [a core subunit in TTT (Tel2-Tti1-Tti2) complex] (19, 20).

Table 1

The components of R2TP in yeast and human.

YeastHumanFeatures
Rvb1RuvBL1/Pontin/TIP49AAA+ superfamily
Rvb2RuvBL2/Reptin/TIP48AAA+ superfamily
Pih1/Nop17PIH1D1PIH1 domain-containing
Tah1RPAP3TPR domain-containing
Figure 1 Functions of Rvbs (Rvb1-Rvb2) and R2TP complexes.Rvbs are involved in transcriptional regulation, DNA repair, telomerase assembly, and mitotic spindle assembly [reviewed in (3, 5, 12)]. In contrast, R2TP is involved in apoptosis, PIKK signaling (functions in stress responses including DNA repair, transcription, and mRNA decay), and snoRNP biogenesis [reviewed in (2, 4)]. This change in functional profile of the Rvbs is achieved by Pih1/PIH1D1 assisting the binding of Rvbs and Tah1/RPAP3 to the specific targets such as Nop58 (box C/D snoRNP), dyskerin (box H/ACA snoRNP), Rpb1 (RNA polymerase II), and Tel2 [TTT (Tel2-Tti1-Tti2) complex, which mediates interaction with PIKK complexes]. Target proteins/complexes of Rvbs or R2TP in each cellular process are shown in the box.
Figure 1

Functions of Rvbs (Rvb1-Rvb2) and R2TP complexes.

Rvbs are involved in transcriptional regulation, DNA repair, telomerase assembly, and mitotic spindle assembly [reviewed in (3, 5, 12)]. In contrast, R2TP is involved in apoptosis, PIKK signaling (functions in stress responses including DNA repair, transcription, and mRNA decay), and snoRNP biogenesis [reviewed in (2, 4)]. This change in functional profile of the Rvbs is achieved by Pih1/PIH1D1 assisting the binding of Rvbs and Tah1/RPAP3 to the specific targets such as Nop58 (box C/D snoRNP), dyskerin (box H/ACA snoRNP), Rpb1 (RNA polymerase II), and Tel2 [TTT (Tel2-Tti1-Tti2) complex, which mediates interaction with PIKK complexes]. Target proteins/complexes of Rvbs or R2TP in each cellular process are shown in the box.

In this review, we will focus on describing the R2TP function in snoRNP biogenesis. snoRNP biogenesis is essential for cell growth and proliferation in eukaryotes because snoRNPs are involved in pre-rRNA modification, which in turn regulates ribosome biogenesis (21–23). There are two major classes of snoRNAs – box C/D and box H/ACA snoRNAs – which function as guide RNA, targeting snoRNPs to specific nucleotides on pre-rRNA for enzymatic modifications, such as 2′-O-methylation and pseudouridylation, respectively (Figure 2) (24, 25). Recent studies have shown that the R2TP functions as a chaperone for the both box C/D and box H/ACA snoRNP assembly (16, 17), and it regulates ribosome biogenesis and subsequently controls cell proliferation (16, 26). Intriguingly, it has been reported that the expression levels of some components of R2TP, box C/D snoRNP, as well as box H/ACA snoRNP, are deregulated in various cancer cells (described in main section). On the basis of recent data, we discuss how the R2TP contributes to carcinogenesis through regulating snoRNP biogenesis.

Figure 2 Components of the box C/D and box H/ACA snoRNP.Mature form of box C/D and box H/ACA snoRNPs are shown (21). The box C/D snoRNP is composed of box C/D snoRNA and four core proteins: Snu13, Nop1/fibrillarin, Nop56, and Nop58, and is required for 2′-O-methylation of pre-rRNA (21, 23). Nop1 is the catalytic subunit of this complex. The box H/ACA snoRNP is composed of box H/ACA snoRNA and four core proteins – Nhp2, Gar1, Nop10, and Cbf5/dyskerin – and is involved in pseudouridylation of pre-rRNA (21, 23). The box H/ACA snoRNA includes two hairpins and each of these associates with the core protein factors. Cbf5/dyskerin is the catalytic subunit of this snoRNP.
Figure 2

Components of the box C/D and box H/ACA snoRNP.

Mature form of box C/D and box H/ACA snoRNPs are shown (21). The box C/D snoRNP is composed of box C/D snoRNA and four core proteins: Snu13, Nop1/fibrillarin, Nop56, and Nop58, and is required for 2′-O-methylation of pre-rRNA (21, 23). Nop1 is the catalytic subunit of this complex. The box H/ACA snoRNP is composed of box H/ACA snoRNA and four core proteins – Nhp2, Gar1, Nop10, and Cbf5/dyskerin – and is involved in pseudouridylation of pre-rRNA (21, 23). The box H/ACA snoRNA includes two hairpins and each of these associates with the core protein factors. Cbf5/dyskerin is the catalytic subunit of this snoRNP.

R2TP function in box C/D snoRNP biogenesis

The box C/D snoRNP is composed of box C/D snoRNA and the core proteins, Nop1 (fibrillarin in human), Snu13 (15.5K in human), Nop56, and Nop58 (21) (Figure 2). This RNA-protein complex is involved in 2′-O-methylation of the pre-rRNA. The snoRNA moiety functions as guide RNA that forms base pairs with pre-rRNA, which in turn allows the pre-rRNA to be methylated by Nop1/fibrillarin. This modification is essential for the subsequent endonucleotic cleavage and processing of the pre-rRNA to produce mature rRNAs (21, 27). The assembly of snoRNP is hierarchical and its proper assembly is essential for both the activity and stability of snoRNP (6, 16, 17, 28–31). It has been proposed that the assembly of box C/D snoRNP starts with the interaction between box C/D snoRNA and Snu13/15.5k, followed by the binding of Nop58 and then Nop1/fibrillarin and Nop56 are recruited (28, 32). In this process, Nufip/Rsa1 (snoRNP assembly factor) and Rvbs facilitate the assembly of box C/D snoRNP by bridging the interactions of core components of box C/D snoRNP: between 15.5K and both Nop56 and Nop58 (29–31). Nufip is likely to regulate the interaction between Rvbs and the box C/D core proteins by tightly interacting with 15.5K (30). An involvement of R2TP in this assembly process also have been identified in yeast and human (6, 29), and very recently, it was shown that the yeast R2TP specifically associates with unassembled Nop58 which has yet to be assembled with other core factors such as Nop1, Snu13, and Nop56 (16). Under nutrient-rich condition, the yeast R2TP localizes to nucleus and tightly associates with the unassembled Nop58 that stabilizes Nop58. However, under the nutrient-limiting condition, it dissociates from Nop58 and subsequently delocalizes to cytoplasm. Importantly, Pih1 is a key factor in this process. When the yeast Pih1 was artificially tagged with a nuclear export signal and thus was forced to localize only in the cytoplasm, Nop58 protein level was significantly reduced, and cell growth was also severely compromised (16).

Altogether, the current evidence shows that the yeast and human R2TP facilitates/regulates the assembly of box C/D snoRNPs at its very early stage. Intriguingly, the activity and subcellular localization of the yeast R2TP are tightly regulated by growth conditions. During the process, the association of yeast Pih1 with free form of Nop58 is essential and appears to have a direct effect on cell growth (16). However, details on how the R2TP-Nop58 interaction contributes to the following maturation process of box C/D snoRNP remain to be elucidated. Also, it has yet to be determined whether subcellular localization of R2TP and interaction between R2TP and Nop58 in mammalian cells are altered under the different growth conditions.

R2TP function in box H/ACA snoRNP biogenesis

The box H/ACA snoRNP consists of box H/ACA snoRNA, and the core proteins, Nhp2, Gar1, Nop10, and Cbf5 (referred to as dyskerin, NAP57, and DKC1 in human) (21) (Figure 2). Like box C/D snoRNP, box H/ACA snoRNP is also involved in modification of pre-rRNA, which is required for downstream processing. The Cbf5/dyskerin functions as a pseudouridine synthase, thus this RNA-protein complex is responsible for pseudouridylation of the target uridines on the pre-rRNA (33, 34). It has been shown that the box H/ACA snoRNP assembly occurs co-transcriptionally and requires assembly factors, which are not integral components of the mature box H/ACA snoRNP, such as Naf1 and Shq1 (35–37). The Shq1 initially interacts with free form of Cbf5/dyskerin, which has yet to be co-transcriptionally assembled with box H/ACA snoRNA and other core proteins (36, 38). In mammalian systems, R2TP subsequently interacts directly with Shq1-dyskerin complex, resulting in the latter’s dissociation (17). Then, another assembly factor Naf1 interacts with dyskerin and the complex is brought to the transcription sites of box H/ACA snoRNA. Next, Naf1 is replaced by Gar1 to form the mature snoRNP complex by assembling with other factors such as Nhp2, and Nop10 (39). Additionally, given that all core protein factors of box H/ACA snoRNP also assembles with TERC (telomerase RNA component), forming TERC-containing RNP (34), its biogenesis could follow that of canonical box H/ACA snoRNPs by involving R2TP (17). In yeast, Rvbs are involved in box H/ACA snoRNP biogenesis (6, 40), although the contribution of Pih1 and Tah1 to the process, if any, remains unknown.

Deregulation of snoRNA biogenesis in tumorigenesis

A common feature of the cancer cells is abnormally enlarged nucleolus, as a result of hyperactive ribosome biogenesis (41). Consequently, cellular processes that are related to ribosome biogenesis, such as the biosynthesis of ribosomal proteins, rRNA, snoRNAs and core proteins of snoRNPs, are expected to be highly activated (41–44). In support of this argument, the deregulation of snoRNA/snoRNP biogenesis has been reported in various cancer cell types [reviewed in (45)]. Given that rRNA biosynthesis is upregulated in cancer cells, it is reasonable to assume that the expression of snoRNAs will also be upregulated, as they are required for pre-rRNA processing. Nevertheless, while some snoRNAs are indeed upregulated in cancer cells, others are actually downregulated. For example, Mannoor et al. investigated snoRNAs expression in tumor-initiating cells (TICs; also known as cancer stem cells) of non-small cell lung cancer (46). They identified 22 snoRNAs that showed changes in expression by more than threefold in TICs compared to non-TICs. Of these 22 snoRNAs, 21 were upregulated, but one was downregulated (46). Among the upregulated snoRNAs, SNORA42 showed the highest expression. Intriguingly, in TIC xenografts of mice, knock down of SNORA42 resulted in a decrease of tumorigenesis (46). In other cancer cell lines, it has been identified that SNORD33, SNORD44, SNORD66, and SNORD76 are upregulated, and a depletion of their expression decreases both cancer cell growth and colony formation (47, 48). Regarding snoRNA downregulation that is related to tumorigenesis, human U50 box C/D snoRNA (also called SNORD50) is mutated and downregulated in prostate and breast cancers (49, 50). On the other hand, U50 overexpression inhibits colony formation of prostate and breast cancers, suggesting that the U50 functions as a tumor suppressor (49, 50). In mice, deletion of U50 snoRNA decreased methylation levels of the target rRNA, however, no significant growth phenotype or tumorigenesis were observed. Subtle effects on lymphoid organs such as splenomegaly and swollen lymph nodes were observed more frequently compared to wild-type mice (51). Additionally, other snoRNAs (SNORD43, SNORD44 and SNORD48) are known to have decreased expression levels in cancer cells, although it mechanism has not been elucidated (52).

Potential role of R2TP in tumorigenesis through snoRNP pathway

As mentioned above, R2TP is involved in various cellular processes and exerts chaperone function, assisting the assembly of multiprotein complexes via interaction with their specific subunits. As reviewed by Grigoletto et al. (53), RuvBL1/pontin and RuvBL2/reptin are known to be involved in carcinogenic processes of hepatocellular carcinoma as well as colorectal cancer. Although the accumulating data indicates the involvement of RuvBL1/pontin and RuvBL2/reptin in carcinogenesis, the underlying mechanism remains largely unknown. Several reports suggest that the regulatory role of Rvbs/R2TP in snoRNP biogenesis is associated with tumorigenesis. It has been shown that Rvbs and Pih1 as well as Nop56 are co-immunoprecipitated with Nop58 in Hela cells (31). In addition, PIH1D1 depletion resulted in significant decrease of box C/D snoRNAs and accumulation of U3 box C/D snoRNA in Cajal body where snoRNPs transit during its maturation process (31). Furthermore, Su et al. showed that snoRNA/snoRNP biogenesis involving RuvBL1/pontin is enhanced in breast cancer (54). They observed that the depletion of RuvBL1/pontin markedly reduced box C/D snoRNA accumulation, which is significantly upregulated in breast cancer cells. Also, similar effects were observed by impairment of box C/D snoRNP core factors such as fibrillarin, NOP56, and NOP58, suggesting that RuvBL1/pontin and box C/D snoRNP cooperatively contribute to tumorigenesis. Moreover, they showed that a suppression of snoRNA biogenesis compromised tumorigenicity through activating p53 (54).

In addition to snoRNAs, the upregulation of R2TP has also been reported in various cancer cells as shown in Table 2. For example, in human hepatocellular carcinoma (HCC), the mRNA and/or protein levels of RuvBL1/pontin and RuvBL2/reptin are increased as compared to non-tumor liver (55–60). Also, it has been shown that RuvBL1/pontin is overexpressed in breast, colon, and colorectal cancers (61–64) and RuvBL2/reptin is overexpressed in breast, colon, gastric, and renal cell cancers (62, 65–67). Additionally, it has been reported that RPAP3 and PIH1D1 expressions are upregulated in breast cancer as well as colon cancer (62, 68). As aforementioned, R2TP directly targets both Nop58 and dyskerin, which are a component of box C/D and box H/ACA snoRNP, respectively. Interestingly, it has been observed that the expression of the both Nop58 and dyskerin are increased in some cancer cells. For Nop58, the expression level was compared between non-metastic and metastatic melanoma cells from mice, and its expression was significantly increased in metastatic cells (69). Also, in tumor samples of human malignant melanoma, Nop58 is upregulated specifically in metastatic group compared to the non-metastatic group (69). For dyskerin, although downregulation of the expression has been observed in a subset of tumors (70), upregulated expression was determined in a number of human cancer cells and also its overexpression is correlated with aggressive proliferation of the tumor cells such as hepatocellular (71), colon (72), prostate (73, 74), head and neck carcinomas (75). Given that the both Nop58 and dyskerin are unstable proteins and associated/stabilized by R2TP (16, 17, 76), the expression level of R2TP components also might be upregulated to maintain the target proteins level in above-mentioned cancers.

Table 2

The upregulation of R2TP in various cancers.

Upregulated genesTypes of cancerReferences
RuvBL1/PontinHepatocellular carcinoma(55, 57, 60)
Breast cancer(62)
Colon cancer(61, 62)
Colorectal cancer(63, 64)
RuvBL2/ReptinHepatocellular carcinoma(55, 56, 58–60)
Breast cancer(62, 66)
Colon cancer(62)
Gastric cancer(65)
Renal cell cancer(67)
RPAP3Breast cancer(62)
Colon cancer(62)
PIH1D1Breast cancer(62, 68)
Colon cancer(62)

In summary, it is shown how R2TP function is related to tumorigenesis through snoRNP biogenesis (Figure 3). R2TP directly interacts with Nop58 and dyskerin, a component of box C/D and box H/ACA snoRNP (16, 17). R2TP stabilizes Nop58 protein level, and facilitates the assembly with other core components (16). For dyskerin, R2TP dissociates it from the associated protein Shq1 to promote the following assembly process (17). In cancer cells, some of the R2TP and snoRNP components as well as many snoRNAs are upregulated to enhance the snoRNP synthesis to process the pre-rRNA efficiently and to produce high amount of ribosome. This elevated snoRNP and ribosome biogenesis negatively regulates the tumor suppressor p53 and that triggers tumorigenesis, whereas inhibition of the snoRNP synthesis in cancer cells induces ribosome stress, which activates p53 and inhibits cell proliferation (54). In this context, R2TP is a crucial regulator of cell proliferation. To downregulate the highly activated snoRNP/ribosome biogenesis in cancer cells, inhibition of the ATPase activity of R2TP and/or blocking its interaction with Nop58, and dyskerin could be considered a promising therapeutic approach. Thus, R2TP has great potential as a drug target for future cancer therapeutic research and development.

Figure 3 Involvement of R2TP in cell proliferation/tumorigenesis through snoRNP biogenesis.R2TP regulates both box C/D and box H/ACA snoRNP biogenesis, and subsequently controls pre-rRNA processing, ribosome biogenesis, and cell proliferation. Elevated snoRNP biogenesis inactivates p53 activity and triggers tumorigenesis, whereas inhibition of snoRNP biogenesis activates p53 and inhibits the cell proliferation.
Figure 3

Involvement of R2TP in cell proliferation/tumorigenesis through snoRNP biogenesis.

R2TP regulates both box C/D and box H/ACA snoRNP biogenesis, and subsequently controls pre-rRNA processing, ribosome biogenesis, and cell proliferation. Elevated snoRNP biogenesis inactivates p53 activity and triggers tumorigenesis, whereas inhibition of snoRNP biogenesis activates p53 and inhibits the cell proliferation.

Corresponding author: Yoshito Kakihara, Division of Dental Pharmacology, Department of Dentistry, Niigata University, 2-5274 Gakkocho-dori, Chuo-ku, Niigata, 951-8514, Japan, e-mail:

Acknowledgments

We thank Dr. Keith Wong (University of Toronto, Canada) for critical reading of the manuscript. This work was supported in part by Japan Society for the Promotion of Science Grants C24592795 and the Osaka Medical Research Foundation for Incurable Diseases.

List of abbreviations
snoRNA

small nucleolar RNA

snoRNP

small nucleolar ribonucleoprotein

PIKK

phosphatidylinositol 3-kinase-related kinase

rRNA

ribosomal RNA

References

1. Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, Parsons AB, Krogan N, Cagney G, Mai D, Greenblatt J, Boone C, Emili A, Houry WA. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005; 120: 715–27.10.1016/j.cell.2004.12.024Suche in Google Scholar PubMed

2. Boulon S, Bertrand E, Pradet-Balade B. HSP90 and the R2TP co-chaperone complex: building multi-protein machineries essential for cell growth and gene expression. RNA Biol 2012; 9: 148–54.10.4161/rna.18494Suche in Google Scholar PubMed

3. Nano N, Houry WA. Chaperone-like activity of the AAA+ proteins Rvb1 and Rvb2 in the assembly of various complexes. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20110399.10.1098/rstb.2011.0399Suche in Google Scholar PubMed PubMed Central

4. Kakihara Y, Houry WA. The R2TP complex: discovery and functions. Biochim Biophys Acta 2012; 1823: 101–7.10.1016/j.bbamcr.2011.08.016Suche in Google Scholar PubMed

5. Huen J, Kakihara Y, Ugwu F, Cheung KL, Ortega J, Houry WA. Rvb1-Rvb2: essential ATP-dependent helicases for critical complexes. Biochem Cell Biol 2010; 88: 29–40.10.1139/O09-122Suche in Google Scholar PubMed

6. Zhao R, Kakihara Y, Gribun A, Huen J, Yang G, Khanna M, Costanzo M, Brost RL, Boone C, Hughes TR, Yip CM, Houry WA. Molecular chaperone Hsp90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation. J Cell Biol 2008; 180: 563–78.10.1083/jcb.200709061Suche in Google Scholar PubMed PubMed Central

7. Ducat D, Kawaguchi S, Liu H, Yates JR, 3rd, Zheng Y. Regulation of microtubule assembly and organization in mitosis by the AAA+ ATPase Pontin. Mol Biol Cell 2008; 19: 3097–110.10.1091/mbc.e07-11-1202Suche in Google Scholar PubMed PubMed Central

8. Venteicher AS, Meng Z, Mason PJ, Veenstra TD, Artandi SE. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 2008; 132: 945–57.10.1016/j.cell.2008.01.019Suche in Google Scholar PubMed PubMed Central

9. Ohdate H, Lim CR, Kokubo T, Matsubara K, Kimata Y, Kohno K. Impairment of the DNA binding activity of the TATA-binding protein renders the transcriptional function of Rvb2p/Tih2p, the yeast RuvB-like protein, essential for cell growth. J Biol Chem 2003; 278: 14647–56.10.1074/jbc.M213220200Suche in Google Scholar PubMed

10. Gallant P. Control of transcription by Pontin and Reptin. Trends Cell Biol 2007; 17: 187–92.10.1016/j.tcb.2007.02.005Suche in Google Scholar PubMed

11. Dugan KA, Wood MA, Cole MD. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis. Oncogene 2002; 21: 5835–43.10.1038/sj.onc.1205763Suche in Google Scholar PubMed

12. Jha S, Dutta A. RVB1/RVB2: running rings around molecular biology. Mol Cell 2009; 34: 521–33.10.1016/j.molcel.2009.05.016Suche in Google Scholar PubMed PubMed Central

13. Rosenbaum J, Baek SH, Dutta A, Houry WA, Huber O, Hupp TR, Matias PM. The emergence of the conserved AAA+ ATPases Pontin and Reptin on the signaling landscape. Sci Signal 2013; 6: mr1.10.1126/scisignal.2003906Suche in Google Scholar PubMed PubMed Central

14. Shevchenko A, Roguev A, Schaft D, Buchanan L, Habermann B, Sakalar C, Thomas H, Krogan NJ, Shevchenko A, Stewart AF. Chromatin central: towards the comparative proteome by accurate mapping of the yeast proteomic environment. Genome Biol 2008; 9: R167.10.1186/gb-2008-9-11-r167Suche in Google Scholar PubMed PubMed Central

15. Stirling PC, Bloom MS, Solanki-Patil T, Smith S, Sipahimalani P, Li Z, Kofoed M, Ben-Aroya S, Myung K, Hieter P. The complete spectrum of yeast chromosome instability genes identifies candidate CIN cancer genes and functional roles for ASTRA complex components. PLoS Genet 2011; 7: e1002057.10.1371/journal.pgen.1002057Suche in Google Scholar PubMed PubMed Central

16. Kakihara Y, Makhnevych T, Zhao L, Tang W, Houry WA. Nutritional status modulates box C/D snoRNP biogenesis by regulated subcellular relocalization of the R2TP complex. Genome Biol 2014; 15: 404.10.1186/s13059-014-0404-4Suche in Google Scholar PubMed PubMed Central

17. Machado-Pinilla R, Liger D, Leulliot N, Meier UT. Mechanism of the AAA+ ATPases pontin and reptin in the biogenesis of H/ACA RNPs. RNA 2012; 18: 1833–45.10.1261/rna.034942.112Suche in Google Scholar PubMed PubMed Central

18. Boulon S, Pradet-Balade B, Verheggen C, Molle D, Boireau S, Georgieva M, Azzag K, Robert MC, Ahmad Y, Neel H, Lamond AI, Bertrand E. HSP90 and its R2TP/Prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II. Mol Cell 2010; 39: 912–24.10.1016/j.molcel.2010.08.023Suche in Google Scholar PubMed PubMed Central

19. Horejsi Z, Takai H, Adelman CA, Collis SJ, Flynn H, Maslen S, Skehel JM, de Lange T, Boulton SJ. CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability. Mol Cell 2010; 39: 839–50.10.1016/j.molcel.2010.08.037Suche in Google Scholar PubMed

20. Horejsi Z, Stach L, Flower TG, Joshi D, Flynn H, Skehel JM, O’Reilly NJ, Ogrodowicz RW, Smerdon SJ, Boulton SJ. Phosphorylation-dependent PIH1D1 interactions define substrate specificity of the R2TP cochaperone complex. Cell Rep 2014; 7: 19–26.10.1016/j.celrep.2014.03.013Suche in Google Scholar PubMed PubMed Central

21. Watkins NJ, Bohnsack MT. The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA. Wiley Interdiscip Rev RNA 2012; 3: 397–414.10.1002/wrna.117Suche in Google Scholar

22. Gerbi SA, Borovjagin AV, Lange TS. The nucleolus: a site of ribonucleoprotein maturation. Curr Opin Cell Biol 2003; 15: 318–25.10.1016/S0955-0674(03)00049-8Suche in Google Scholar

23. Tollervey D, Hurt EC. The role of small nucleolar ribonucleoproteins in ribosome synthesis. Mol Biol Rep 1990; 14: 103–6.10.1007/BF00360433Suche in Google Scholar

24. Peculis BA. RNA-binding proteins: if it looks like a sn(o)RNA. Curr Biol 2000; 10: R916–8.10.1016/S0960-9822(00)00851-4Suche in Google Scholar

25. Kiss T. SnoRNP biogenesis meets Pre-mRNA splicing. Mol Cell 2006; 23: 775–6.10.1016/j.molcel.2006.08.023Suche in Google Scholar

26. King TH, Liu B, McCully RR, Fournier MJ. Ribosome structure and activity are altered in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center. Mol Cell 2003; 11: 425–35.10.1016/S1097-2765(03)00040-6Suche in Google Scholar

27. Venema J, Tollervey D. Ribosome synthesis in Saccharomyces cerevisiae. Ann Rev Genet 1999; 33: 261–311.10.1146/annurev.genet.33.1.261Suche in Google Scholar PubMed

28. Watkins NJ, Dickmanns A, Luhrmann R. Conserved stem II of the box C/D motif is essential for nucleolar localization and is required, along with the 15.5K protein, for the hierarchical assembly of the box C/D snoRNP. Mol Cell Biol 2002; 22: 8342–52.10.1128/MCB.22.23.8342-8352.2002Suche in Google Scholar PubMed PubMed Central

29. Boulon S, Marmier-Gourrier N, Pradet-Balade B, Wurth L, Verheggen C, Jady BE, Rothé B, Pescia C, Robert MC, Kiss T, Bardoni B, Krol A, Branlant C, Allmang C, Bertrand E, Charpentier B. The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery. J Cell Biol 2008; 180: 579–95.10.1083/jcb.200708110Suche in Google Scholar PubMed PubMed Central

30. McKeegan KS, Debieux CM, Watkins NJ. Evidence that the AAA+ proteins TIP48 and TIP49 bridge interactions between 15.5K and the related NOP56 and NOP58 proteins during box C/D snoRNP biogenesis. Mol Cell Biol 2009; 29: 4971–81.10.1128/MCB.00752-09Suche in Google Scholar PubMed PubMed Central

31. McKeegan KS, Debieux CM, Boulon S, Bertrand E, Watkins NJ. A dynamic scaffold of pre-snoRNP factors facilitates human box C/D snoRNP assembly. Mol Cell Biol 2007; 27: 6782–93.10.1128/MCB.01097-07Suche in Google Scholar PubMed PubMed Central

32. Omer AD, Ziesche S, Ebhardt H, Dennis PP. In vitro reconstitution and activity of a C/D box methylation guide ribonucleoprotein complex. Proc Natl Acad Sci USA 2002; 99: 5289–94.10.1073/pnas.082101999Suche in Google Scholar PubMed PubMed Central

33. Hamma T, Ferre-D’Amare AR. The box H/ACA ribonucleoprotein complex: interplay of RNA and protein structures in post-transcriptional RNA modification. J Biol Chem 2010; 285: 805–9.10.1074/jbc.R109.076893Suche in Google Scholar PubMed PubMed Central

34. Meier UT. How a single protein complex accommodates many different H/ACA RNAs. Trends Biochem Sci 2006; 31: 311–5.10.1016/j.tibs.2006.04.002Suche in Google Scholar PubMed PubMed Central

35. Dez C, Noaillac-Depeyre J, Caizergues-Ferrer M, Henry Y. Naf1p, an essential nucleoplasmic factor specifically required for accumulation of box H/ACA small nucleolar RNPs. Mol Cell Biol 2002; 22: 7053–65.10.1128/MCB.22.20.7053-7065.2002Suche in Google Scholar PubMed PubMed Central

36. Yang PK, Rotondo G, Porras T, Legrain P, Chanfreau G. The Shq1p.Naf1p complex is required for box H/ACA small nucleolar ribonucleoprotein particle biogenesis. J Biol Chem 2002; 277: 45235–42.10.1074/jbc.M207669200Suche in Google Scholar PubMed

37. Yang PK, Hoareau C, Froment C, Monsarrat B, Henry Y, Chanfreau G. Cotranscriptional recruitment of the pseudouridylsynthetase Cbf5p and of the RNA binding protein Naf1p during H/ACA snoRNP assembly. Mol Cell Biol 2005; 25: 3295–304.10.1128/MCB.25.8.3295-3304.2005Suche in Google Scholar PubMed PubMed Central

38. Grozdanov PN, Fernandez-Fuentes N, Fiser A, Meier UT. Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita. Hum Mol Genet 2009; 18: 4546–51.10.1093/hmg/ddp416Suche in Google Scholar PubMed PubMed Central

39. Darzacq X, Kittur N, Roy S, Shav-Tal Y, Singer RH, Meier UT. Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells. J Cell Biol 2006; 173: 207–18.10.1083/jcb.200601105Suche in Google Scholar PubMed PubMed Central

40. King TH, Decatur WA, Bertrand E, Maxwell ES, Fournier MJ. A well-connected and conserved nucleoplasmic helicase is required for production of box C/D and H/ACA snoRNAs and localization of snoRNP proteins. Mol Cell Biol 2001; 21: 7731–46.10.1128/MCB.21.22.7731-7746.2001Suche in Google Scholar PubMed PubMed Central

41. Quin JE, Devlin JR, Cameron D, Hannan KM, Pearson RB, Hannan RD. Targeting the nucleolus for cancer intervention. Biochim Biophys Acta 2014; 1842: 802–16.10.1016/j.bbadis.2013.12.009Suche in Google Scholar

42. Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S, Textoris J, Prats AC, Mertani HC, Dumontet C, Diaz JJ. Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PloS One 2009; 4: e7147.10.1371/journal.pone.0007147Suche in Google Scholar

43. Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer 2010; 10: 254–66.10.1038/nrc2824Suche in Google Scholar

44. Leary DJ, Huang S. Regulation of ribosome biogenesis within the nucleolus. FEBS Lett 2001; 509: 145–50.10.1016/S0014-5793(01)03143-XSuche in Google Scholar

45. Nallar SC, Kalvakolanu DV. Regulation of snoRNAs in cancer: close encounters with interferon. J Interferon Cytokine Res 2011; 33: 189–98.Suche in Google Scholar

46. Mannoor K, Shen J, Liao J, Liu Z, Jiang F. Small nucleolar RNA signatures of lung tumor-initiating cells. Mol Cancer 2014; 13: 104.10.1186/1476-4598-13-104Suche in Google Scholar

47. Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, Liu Z, Jiang F. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 2010; 9: 198.10.1186/1476-4598-9-198Suche in Google Scholar

48. Appaiah HN, Goswami CP, Mina LA, Badve S, Sledge GW, Jr., Liu Y, Nakshatri H. Persistent upregulation of U6: SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res 2011; 13: R86.10.1186/bcr2943Suche in Google Scholar

49. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, Petros J, Li Q, Vessella RL, Kibel AS, Stevens VL, Calle EE, Dong J-T. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 2008; 17: 1031–42.10.1093/hmg/ddm375Suche in Google Scholar

50. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W, Dong JT. Implication of snoRNA U50 in human breast cancer. J Genet Genomics 2009; 36: 447–54.10.1016/S1673-8527(08)60134-4Suche in Google Scholar

51. Soeno Y, Fujita K, Kudo T, Asagiri M, Kakuta S, Taya Y, Shimazu Y, Sato K, Tanaka-Fujita R, Kubo S, Iwakura Y, Nakamura Y, Mori S, Aoba T. Generation of a mouse model with down-regulated U50 snoRNA (SNORD50) expression and its organ-specific phenotypic modulation. PloS One 2013; 8: e72105.10.1371/journal.pone.0072105Suche in Google Scholar PubMed PubMed Central

52. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, West C, Ragoussis J, Harris AL. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 2011; 104: 1168–77.10.1038/sj.bjc.6606076Suche in Google Scholar PubMed PubMed Central

53. Grigoletto A, Lestienne P, Rosenbaum J. The multifaceted proteins Reptin and Pontin as major players in cancer. Biochim Biophys Acta 2011; 1815: 147–57.10.1016/j.bbcan.2010.11.002Suche in Google Scholar PubMed

54. Su H, Xu T, Ganapathy S, Shadfan M, Long M, Huang TH, Thompson I, Yuan ZM. Elevated snoRNA biogenesis is essential in breast cancer. Oncogene 2014; 33: 1348–58.10.1038/onc.2013.89Suche in Google Scholar PubMed

55. Acevedo LG, Bieda M, Green R, Farnham PJ. Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res 2008; 68: 2641–51.10.1158/0008-5472.CAN-07-5590Suche in Google Scholar PubMed PubMed Central

56. Iizuka N, Tsunedomi R, Tamesa T, Okada T, Sakamoto K, Hamaguchi T, Yamada-Okabe H, Miyamoto T, Uchimura S, Hamamoto Y, Oka M. Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus. J Cancer Res Clin Oncol 2006; 132: 473–81.10.1007/s00432-006-0094-8Suche in Google Scholar PubMed

57. Li C, Tan YX, Zhou H, Ding SJ, Li SJ, Ma DJ, Man XB, Hong Y, Zhang L, Li L, Xia QC, Wu JR, Wang HY, Zeng R. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: identification of potential tumor markers. Proteomics 2005; 5: 1125–39.10.1002/pmic.200401141Suche in Google Scholar PubMed

58. Blanc JF, Lalanne C, Plomion C, Schmitter JM, Bathany K, Gion JM, Bioulac-Sage P, Balabaud C, Bonneu M, Rosenbaum J. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005; 5: 3778–89.10.1002/pmic.200401194Suche in Google Scholar PubMed

59. Rousseau B, Menard L, Haurie V, Taras D, Blanc JF, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemière S, Canron X, Costet P, Cole M, Balabaud C, Bioulac-Sage P, Zucman-Rossi J, Rosenbaum J. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 2007; 46: 1108–18.10.1002/hep.21770Suche in Google Scholar PubMed

60. Haurie V, Menard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P, Prats H, Zucman-Rossi J, Rosenbaum J. Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Hepatology 2009; 50: 1871–83.10.1002/hep.23215Suche in Google Scholar PubMed PubMed Central

61. Carlson ML, Wilson ET, Prescott SM. Regulation of COX-2 transcription in a colon cancer cell line by Pontin52/TIP49a. Mol Cancer 2003; 2: 42.10.1186/1476-4598-2-42Suche in Google Scholar PubMed PubMed Central

62. Kim SG, Hoffman GR, Poulogiannis G, Buel GR, Jang YJ, Lee KW, Kim BY, Erikson RL, Cantley LC, Choo AY, Blenis J. Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. Mol Cell 2013; 49: 172–85.10.1016/j.molcel.2012.10.003Suche in Google Scholar

63. Lauscher JC, Loddenkemper C, Kosel L, Grone J, Buhr HJ, Huber O. Increased pontin expression in human colorectal cancer tissue. Hum Pathol 2007; 38: 978–85.10.1016/j.humpath.2007.01.005Suche in Google Scholar

64. Lauscher JC, Elezkurtaj S, Dullat S, Lipka S, Gröne J, Buhr HJ, Huber O, Kruschewski M. Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma. Oncol Rep 2012; 28: 1619–24.10.3892/or.2012.1968Suche in Google Scholar

65. Li W, Zeng J, Li Q, Zhao L, Liu T, Björkholm M, Jia J, Xu D. Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Mol Cancer 2010; 9: 132.10.1186/1476-4598-9-132Suche in Google Scholar

66. Maslon MM, Hrstka R, Vojtesek B, Hupp TR. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin. J Mol Biol 2010; 404: 418–38.10.1016/j.jmb.2010.09.035Suche in Google Scholar

67. Ren J, Li W, Liu H, Yan L, Jiao W, Li D, Tang Y, Gu G, Xu Z. Overexpression of Reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells. Urol Oncol 2013; 7: 1358–66.10.1016/j.urolonc.2012.01.004Suche in Google Scholar

68. Kamano Y, Saeki M, Egusa H, Kakihara Y, Houry WA, Yatani H, Kamisaki Y. PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription. FEBS letters 2013; 587: 3303–8.10.1016/j.febslet.2013.09.001Suche in Google Scholar

69. Nakamoto K, Ito A, Watabe K, Koma Y, Asada H, Yoshikawa K, Shinomura Y, Matsuzawa Y, Nojima H, Kitamura Y. Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function. Am J Pathol 2001; 159: 1363–74.10.1016/S0002-9440(10)62523-0Suche in Google Scholar

70. Montanaro L. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer. J Pathol 2010; 222: 345–9.10.1002/path.2777Suche in Google Scholar PubMed

71. Liu B, Zhang J, Huang C, Liu H. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. PloS One 2012; 7: e43147.10.1371/journal.pone.0043147Suche in Google Scholar PubMed PubMed Central

72. Turano M, Angrisani A, De Rosa M, Izzo P, Furia M. Real-time PCR quantification of human DKC1 expression in colorectal cancer. Acta Oncol 2008; 47: 1598–9.10.1080/02841860801898616Suche in Google Scholar PubMed

73. Sieron P, Hader C, Hatina J, Engers R, Wlazlinski A, Muller M, Schulz WA. DKC1 overexpression associated with prostate cancer progression. Br J Cancer 2009; 101: 1410–6.10.1038/sj.bjc.6605299Suche in Google Scholar PubMed PubMed Central

74. Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, Storci G, Santini D, Ceccarelli C, Taffurelli M, Carnicelli D, Brigotti M, Bonafè M, Treré D, Derenzini M. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res 2010; 70: 4767–77.10.1158/0008-5472.CAN-09-4024Suche in Google Scholar PubMed

75. Alawi F, Lin P, Ziober B, Patel R. Correlation of dyskerin expression with active proliferation independent of telomerase. Head Neck 2011; 33: 1041–51.10.1002/hed.21579Suche in Google Scholar PubMed PubMed Central

76. Grozdanov PN, Roy S, Kittur N, Meier UT. SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. RNA 2009; 15: 1188–97.10.1261/rna.1532109Suche in Google Scholar PubMed PubMed Central

Received: 2014-8-12
Accepted: 2014-9-11
Published Online: 2014-10-28
Published in Print: 2014-12-1

©2014 by De Gruyter

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. MicroRNAs as therapeutic targets in cardiomyopathies: myth or reality?
  4. Male infertility: biomolecular aspects
  5. Latrophilins updated
  6. Peptide-based vectors: recent developments
  7. C-terminal binding proteins: central players in development and disease
  8. Short Conceptual Overview
  9. The R2TP chaperone complex: its involvement in snoRNP assembly and tumorigenesis
https://doi.org/10.1515/bmc-2014-0028
Schlagwörter für diesen Artikel
box C/D snoRNP; box H/ACA snoRNP; R2TP; snoRNP biogenesis; tumorigenesis
Creative Commons
BY-NC-ND 3.0

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. MicroRNAs as therapeutic targets in cardiomyopathies: myth or reality?
  4. Male infertility: biomolecular aspects
  5. Latrophilins updated
  6. Peptide-based vectors: recent developments
  7. C-terminal binding proteins: central players in development and disease
  8. Short Conceptual Overview
  9. The R2TP chaperone complex: its involvement in snoRNP assembly and tumorigenesis
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 19.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/bmc-2014-0028/html
Button zum nach oben scrollen